This is a systematic review on particle beam including proton and carbon ion therapy for primary or recurrent nasopharyngeal cancer (NPC). Twenty-six eligible...

This retrospective study evaluated 22 patients with thyroid cancer treated with PBT to a total dose of 60 GyRBE adjuvantly and 70 GyRBE for gross disease. With...

This study by the NCC group Korea reported results of PBT as an initial treatment for 46 treatment-naïve hepatocellular carcinoma (HCC) patients. With a median...

This review included 10 studies representing 1,718 patients. A pooled analysis was performed to evaluate the relationship between lymphopenia and overall...

This study from Japan reported clinical outcomes of 43 patient with operable stage IA or IB NSCLC treated with a dose of 66 GyRBE in 10 fractions for peripheral...

This review included 11 studies representing a total of 529 patients. The findings include 1) the OS for 2 years varied from 91% - 98% for 5 of the included...

Based on 21 original studies, this meta-analysis reported a significant association of PT with a superior 5-year OS rate compared to three-dimensional conformal...

Published by the Upenn group, this study reported reduced xerostomia with FLASH proton compared to standard proton therapy in mice. The head and neck area of...

Radiation induced heart disease (RIHD) significantly impacts the long-term survival and quality of life of cancer survivors as one of the most devastating...

This article describes the POWER registry set up by the European Institute of Oncology (IEO), Milan, Italy. All patients with any type of oncologic disease...